ND-014 (NewDEL Biotech)

N/A

Report date: 2025/04/18 09:22:17
NME

Base Information

Drug NameND-014 (NewDEL Biotech)
Drug Alias NameND-014
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShenzhen NewDEL Biotech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShenzhen NewDEL Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A